Table 4. Comparison between travellers and field data for the pfcrt 76 and pfdhfr 108 molecular markers and for the CQ in vitro susceptibility in Senegal.

	Country	Travellers Slope [95% CI*]	Field Study Slope [95% CI]	p-value**
Pfcrt 76	Senegal	−0.167 [−0.219; −0.115]	−0.208 [−0.312; −0.105]	0.575
	Mali	−0.009 [−0.082; 0.063]	0.005 [−0.106; 0.116]	0.885
	Cote d’Ivoire	−0.146 [−0.215; −0.078]	−0.215 [−0.463; 0.032]	0.578
	Cameroon	−0.090 [−0.146; −0.033]	0.050 [−0.220; 0.321]	0.264
Pfdhfr 108	Senegal	0.117 [0.088; 0.147]	0.148 [0.088; 0.209]	0.386
	Mali	0.182 [0.124; 0.240]	0.119 [0.086; 0.152]	0.116
	Cote d’Ivoire	0.083 [0.052; 0.113]	0.132 [−0.025; 0.289]	0.484
	Cameroon	0.213 [0.115; 0.311]	0.130 [−0.155; 0.415]	0.753
CQ in vitro analysis	Senegal	−0.050 [−0.085; −0.015]	−0.028 [−0.059; 0.002]	0.264

^*CI = confidence interval,

^**The p-value indicates whether the fitted slopes for travellers data and field studies were significantly different from each other.